Alcoholic liver disease
Alcoholic liver disease is a term that encompasses the liver manifestations of alcohol overconsumption, including fatty liver, alcoholic hepatitis, and chronic hepatitis with liver fibrosis or cirrhosis. It is the major cause of liver disease in Western countries. According to the World Health Organization, alcoholism is the third leading cause of death in the world.

Etiology
Alcoholic liver disease is caused by heavy alcohol use. The relationship between alcohol consumption and risk of liver disease is dose-dependent. The risk is higher for those who consume more than 40 grams of alcohol per day for men, and more than 20 grams per day for women, over a period of 10 years or more.
Pathogenesis
The pathogenesis of alcoholic liver disease involves a complex interaction of several mechanisms, including oxidative stress, lipid peroxidation, and cytokine production. Alcohol metabolism in the liver generates reactive oxygen species, which can damage liver cells and lead to inflammation and fibrosis.
Clinical Features
The clinical features of alcoholic liver disease depend on the stage of the disease. Early stages may be asymptomatic, while advanced stages may present with jaundice, ascites, hepatic encephalopathy, and variceal bleeding.
Diagnosis
The diagnosis of alcoholic liver disease is based on a combination of history, physical examination, and laboratory tests. Imaging studies such as ultrasound, CT scan, and MRI may also be used.
Treatment
The mainstay of treatment for alcoholic liver disease is abstinence from alcohol. Other treatments may include nutritional support, medications to reduce inflammation and fibrosis, and in severe cases, liver transplantation.
Prognosis
The prognosis of alcoholic liver disease varies depending on the stage of the disease and the patient's ability to abstain from alcohol. Early stages of the disease may be reversible with abstinence, while advanced stages may lead to liver failure and death.
See Also

This article is a gastroenterology stub. You can help WikiMD by expanding it!
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
Start your transformation today with W8MD weight loss centers.
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian